Vertex Pharmaceuticals

493.96
1.49 (0.30%)
At close: Apr 25, 2025, 3:59 PM
494.80
0.17%
After-hours: Apr 25, 2025, 05:56 PM EDT

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals reported an annual revenue of $11.02B, reflecting a 11.66% growth. For the quarter ending December 31, 2024, Vertex Pharmaceuticals generated $2.91B in revenue.
Revenue (ttm)
$11.02B
Revenue Growth
11.66%
Price / Sales Ratio
9.41
Revenue / Employee
$1.81M
Employees
6,100
Market Cap
126.99B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 11.02B +11.66%
Dec 31, 2023 9.87B +10.51%
Dec 31, 2022 8.93B +17.91%
Dec 31, 2021 7.57B +22.06%
Dec 31, 2020 6.21B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.